A randomized-controlled trial concerning effectiveness and safety of 4Fr.ENPBD

A randomized-controlled trial concerning effectiveness and safety of 4Fr.ENPBD - A randomized-controlled trial of 4Fr.ENPBD

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000009415

Enrollment

400

Registered

2012-11-27

Start date

2011-04-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Disease for which biliary or pancreatic duct drainage is necessary

Interventions

4Fr.ENPBD 5Fr.ENPD and 6Fr.ENBD

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who are expected to use ENPBD tube

Exclusion criteria

Exclusion criteria: Patients who have history of EST or EPBD. Patients who are expected to be undergone EST or EPBD.

Design outcomes

Primary

Measure	Time frame
Incidence of acute pancreatitis and hyperpancreaticamylasemia post placement of ENPBD	—

Countries

Japan

Contacts

Public ContactIshigaki Takashi

Hiroshima University Department of Medicine and Molecular Science

suiken@hiroshima-u.ac.jp082-257-5591

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026